Polygenic risk for neuropsychiatric disease and vulnerability to abnormal deep grey matter development.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 02 2019
Historique:
received: 01 10 2018
accepted: 10 01 2019
entrez: 15 2 2019
pubmed: 15 2 2019
medline: 26 8 2020
Statut: epublish

Résumé

Neuropsychiatric disease has polygenic determinants but is often precipitated by environmental pressures, including adverse perinatal events. However, the way in which genetic vulnerability and early-life adversity interact remains obscure. We hypothesised that the extreme environmental stress of prematurity would promote neuroanatomic abnormality in individuals genetically vulnerable to psychiatric disorders. In 194 unrelated infants (104 males, 90 females), born before 33 weeks of gestation (mean gestational age 29.7 weeks), we combined Magnetic Resonance Imaging with a polygenic risk score (PRS) for five psychiatric pathologies to test the prediction that: deep grey matter abnormalities frequently seen in preterm infants are associated with increased polygenic risk for psychiatric illness. The variance explained by the PRS in the relative volumes of four deep grey matter structures (caudate nucleus, thalamus, subthalamic nucleus and lentiform nucleus) was estimated using linear regression both for the full, mixed ancestral, cohort and a subsample of European infants. Psychiatric PRS was negatively associated with lentiform volume in the full cohort (β = -0.24, p = 8 × 10

Identifiants

pubmed: 30760829
doi: 10.1038/s41598-019-38957-1
pii: 10.1038/s41598-019-38957-1
pmc: PMC6374514
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1976

Subventions

Organisme : Medical Research Council
ID : MR/M021475/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K006355/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG046938
Pays : United States
Organisme : Medical Research Council
ID : MR/J014311/1
Pays : United Kingdom
Organisme : DH | National Institute for Health Research (NIHR)
ID : RP-PG-0707-10154
Pays : International
Organisme : Department of Health
ID : RP-PG-0707-10154
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : G19/2
Pays : United Kingdom

Références

IEEE Trans Med Imaging. 2003 Aug;22(8):1014-25
pubmed: 12906255
Pediatrics. 2005 Feb;115(2):286-94
pubmed: 15687434
Heredity (Edinb). 2005 Sep;95(3):221-7
pubmed: 16077740
Neuroimage. 2006 Aug 1;32(1):70-8
pubmed: 16675269
Pediatrics. 2007 Apr;119(4):759-65
pubmed: 17403847
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Eur J Hum Genet. 2008 Oct;16(10):1164-72
pubmed: 18523454
Lancet Neurol. 2009 Jan;8(1):110-24
pubmed: 19081519
Pediatr Res. 2009 May;65(5):524-9
pubmed: 19127204
Nature. 2009 Oct 8;461(7265):747-53
pubmed: 19812666
Hum Brain Mapp. 2010 Aug;31(8):1174-82
pubmed: 20063301
Psychol Med. 2010 Sep;40(9):1409-22
pubmed: 20085668
Behav Genet. 2010 Mar;40(2):114-24
pubmed: 20112130
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
Neuroimage. 2010 Aug 15;52(2):409-14
pubmed: 20451627
PLoS Med. 2010 Jun 08;7(6):e1000289
pubmed: 20543995
Pediatr Res. 2011 May;69(5 Pt 2):11R-8R
pubmed: 21289534
Cereb Cortex. 2012 May;22(5):1016-24
pubmed: 21772018
Neuroimage. 2012 Feb 1;59(3):2255-65
pubmed: 21985910
Arch Gen Psychiatry. 2012 Jun;69(6):E1-8
pubmed: 22660967
Lancet. 2012 Jun 9;379(9832):2162-72
pubmed: 22682464
Biol Psychiatry. 2013 Mar 15;73(6):525-31
pubmed: 23039932
BMJ. 2012 Dec 04;345:e7961
pubmed: 23212880
Lancet. 2013 Apr 20;381(9875):1371-1379
pubmed: 23453885
PLoS Genet. 2013 Mar;9(3):e1003348
pubmed: 23555274
Neuroimage. 2013 Dec;83:98-102
pubmed: 23770413
Nat Genet. 2013 Sep;45(9):984-94
pubmed: 23933821
J Child Psychol Psychiatry. 2014 Oct;55(10):1068-87
pubmed: 25132410
Bioinformatics. 2015 May 1;31(9):1466-8
pubmed: 25550326
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Neuroimage. 2015 May 1;111:300-11
pubmed: 25747917
Front Syst Neurosci. 2015 Apr 14;9:58
pubmed: 25926780
Nat Genet. 2015 Jul;47(7):702-9
pubmed: 25985137
Neuroimage. 2016 Jan 15;125:456-478
pubmed: 26499811
Transl Psychiatry. 2015 Dec 08;5:e692
pubmed: 26645627
Nat Neurosci. 2016 Mar;19(3):420-431
pubmed: 26854805
Sci Rep. 2017 Feb 10;7:42140
pubmed: 28186152
Ann Neurol. 2017 Aug;82(2):233-246
pubmed: 28719076
Transl Psychiatry. 2017 Aug 1;7(8):e1188
pubmed: 28763065
Psychol Med. 2018 Jul;48(10):1738-1744
pubmed: 29350124

Auteurs

Harriet Cullen (H)

Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, London, SE1 7EH, United Kingdom. harriet.cullen@kcl.ac.uk.

Michelle L Krishnan (ML)

Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, London, SE1 7EH, United Kingdom.
Translational Medicine, Neuroscience and Rare Diseases, Roche Pharmaceutical Research and Early Development, Roche Innovation Centre, 4070 Basel, F. Hoffmann-La Roche, Ltd., Basel, Switzerland.

Saskia Selzam (S)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, United Kingdom.

Gareth Ball (G)

Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, London, SE1 7EH, United Kingdom.
Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Australia.

Alessia Visconti (A)

Department of Twin Research and Genetic Epidemiology, King's College London, London, SE1 7EH, United Kingdom.

Alka Saxena (A)

NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, United Kingdom.

Serena J Counsell (SJ)

Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, London, SE1 7EH, United Kingdom.

Jo Hajnal (J)

Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, London, SE1 7EH, United Kingdom.
Department of Biomedical Engineering, School of Bioengineering and Imaging Sciences, King's College London, London, SE1 7EH, UK.

Gerome Breen (G)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, United Kingdom.
NIHR Biomedical Research Centre for Mental Health, South London and Maudsley NHS Trust, London, UK.

Robert Plomin (R)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, United Kingdom.

A David Edwards (AD)

Centre for the Developing Brain, School of Biomedical Engineering & Imaging Sciences, King's College London, London, SE1 7EH, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH